Article ; Online: Ras in cancer and developmental diseases.
2011 Volume 2, Issue 3, Page(s) 344–358
Abstract: ... updating current knowledge on the contribution of Ras mutations and altered Ras signaling to development ... with a variety of cancers. Interestingly, the oncogenic Ras mutations and the mutations in other components ... tumors, separate studies have identified germline mutations in Ras and various other components of Ras ...
| Abstract | Somatic, gain-of-function mutations in ras genes were the first specific genetic alterations identified in human cancer about 3 decades ago. Studies during the last quarter century have characterized the Ras proteins as essential components of signaling networks controlling cellular proliferation, differentiation, or survival. The oncogenic mutations of the H-ras, N-ras, or K-ras genes frequently found in human tumors are known to throw off balance the normal outcome of those signaling pathways, thus leading to tumor development. Oncogenic mutations in a number of other upstream or downstream components of Ras signaling pathways (including membrane RTKs or cytosolic kinases) have been detected more recently in association with a variety of cancers. Interestingly, the oncogenic Ras mutations and the mutations in other components of Ras/MAPK signaling pathways appear to be mutually exclusive events in most tumors, indicating that deregulation of Ras-dependent signaling is the essential requirement for tumorigenesis. In contrast to sporadic tumors, separate studies have identified germline mutations in Ras and various other components of Ras signaling pathways that occur in specific association with a number of different familial, developmental syndromes frequently sharing common phenotypic cardiofaciocutaneous features. Finally, even without being a causative force, defective Ras signaling has been cited as a contributing factor to many other human illnesses, including diabetes and immunological and inflammatory disorders. We aim this review at summarizing and updating current knowledge on the contribution of Ras mutations and altered Ras signaling to development of various tumoral and nontumoral pathologies. |
|---|---|
| Language | English |
| Publishing date | 2011-07-14 |
| Publishing country | United States |
| Document type | Journal Article |
| ZDB-ID | 2538519-7 |
| ISSN | 1947-6027 ; 1947-6019 |
| ISSN (online) | 1947-6027 |
| ISSN | 1947-6019 |
| DOI | 10.1177/1947601911411084 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.